The price tag on progress - Chemotherapy for colorectal cancer Journal Article
| Author: | Schrag, D. |
| Article Title: | The price tag on progress - Chemotherapy for colorectal cancer |
| Keywords: | cancer chemotherapy; cancer survival; review; bevacizumab; fluorouracil; systemic therapy; antineoplastic agents; united states; capecitabine; colorectal cancer; metastasis; antineoplastic combined chemotherapy protocols; camptothecin; cytotoxicity; food and drug administration; cetuximab; irinotecan; monoclonal antibody; colorectal neoplasms; drug cost; law; medicare; drug costs; antibodies, monoclonal; folinic acid; neoplasm metastasis; oxaliplatin; cost benefit analysis; humans; human; priority journal; health care and public health |
| Journal Title: | New England Journal of Medicine |
| Volume: | 351 |
| Issue: | 4 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2004-07-22 |
| Start Page: | 317 |
| End Page: | 319 |
| Language: | English |
| DOI: | 10.1056/NEJMp048143 |
| PROVIDER: | scopus |
| PUBMED: | 15269308 |
| DOI/URL: | |
| Notes: | New Engl. J. Med. -- Cited By (since 1996):305 -- Export Date: 16 June 2014 -- CODEN: NEJMA -- Source: Scopus |
